Skip to main content
. 2021 Feb 5;13(2):220. doi: 10.3390/pharmaceutics13020220

Table 3.

PK parameters for oral administration study of ALZ ASDs in rats.

Formulations Crystalline ALZ Eudragit ASD HPMCAS ASD PVPVA ASD
Cmax (μg/mL) 2.17 ± 0.54 6.30 ± 1.14 8.06 ± 0.81 8.82 ± 1.44
Tmax (h) 3.3 ± 1.2 4.0 ± 0.0 2.0 ± 0.0 2.3 ± 1.5
AUC (μg·hr/mL) 12.7 ± 3.5 37.4 ± 4.9 48.9 ± 5.4 52.4 ± 11.6